— Karim E. Sirgi, MD, MBA, FCAP – CAP Foundation President
Dr. Sirgi is a founding partner and CEO of LambdaX3 International, a health care consulting company focusing on lean management, organizational leadership, and simulation-based learning. Dr. Sirgi is also a founding partner and CEO of Medicolegal Consultants International, a consulting company offering patient safety, peer review, and multispecialty medico-legal expertise. Dr. Sirgi serves on the advisory board of Stem Cell Reserve, a start-up biotech company that develops stem cell-based products for research and regenerative therapies, and of Kirontech, a biotech start-up company specializing in big data analysis and clinical decision support.
Dr. Sirgi is currently the medical director of the Colorado Center for Laboratory Medical Sciences. His recent past leadership activities have included presidency of a multispecialty pathology group, presidency of the medical staff at a tertiary care facility, and chairmanship of the Presidents Council, an advisory board composed of the medical staff leaderships of a seven facilities hospital system. He has also served as chairman of a tertiary care institution’s pathology department and president of the Colorado Society of Clinical Pathologists.
Dr. Sirgi is board certified in anatomic and clinical pathology, with additional subspecialty certification in cytopathology from The University of Texas MD Anderson Cancer Center in Houston and fellowship training in surgical pathology from Barnes-Jewish Hospital, Washington University, in St. Louis, Missouri.
Dr. Martinez-Torres is currently president and chief executive of North Shore Pathologists, SC, in Milwaukee, Wisconsin. He serves as medical staff president and chair of pathology and laboratory medicine for Columbia-St. Mary’s Hospitals and Clinics. Dr. Martinez-Torres is also board president for the Susan G. Komen affiliate in Wisconsin. In addition, he also serves on boards for Columbia-St. Mary’s, the Wisconsin Society of Pathologists, and the Milwaukee Area Pathology Society. Dr. Martinez-Torres attended the University of Illinois College of Medicine and completed his residency and fellowship at the University of California, Davis Medical Center. He is board certified in Anatomic and Clinical Pathology by the American Board of Pathology.
Dr. Harrer, from Haddonfield, New Jersey, recently retired corporate laboratory medical director for the Lourdes Health System in Camden, New Jersey, and Lourdes Medical Center of Burlington County in Willingboro, New Jersey. He was also a professor of pathology, anatomy, and cell biology at Jefferson Medical College in Philadelphia, and clinical professor of pathology at both University of Medicine and Dentistry in New Jersey and Camden County College.
As a former graduate of the University of Buenos Aires, Argentina, Dr. Berho is chair of pathology and laboratory medicine at Cleveland Clinic Florida. She completed her residency at Mount Sinai Medical Center, a fellowship in oncologic surgical pathology at Memorial Sloan Kettering in New York, and a fellowship in immunopathology at the University of Miami. Dr. Berho is a member of the CAP Cancer Protocols Committee. She is also a member of the American Society of Colorectal Surgeons’ Research Foundation Grant Review Committee.
As portfolio manager of the Disruptive Innovation Fund with Rose Park Advisors in Boston, Matthew Q. Christensen adds value to the perspectives of the CAP Foundation board of directors.
With his firm’s strategic focus on “disruptive innovation,” Mr. Christensen identifies the ideas, technologies, issues, and trends that unpredictably impact a market—potential opportunities to capitalize on, or threats likely to affect established incumbents.
Earlier, as a senior associate at Innosight, LLC, in Watertown, Massachusetts, Mr. Christensen led engagements in the biotechnology, enterprise software, and financial services industries, among others. Mr. Christensen also worked at the Boston Consulting Group, where his projects served various industries, including specialty chemicals, telecommunications, technology, and industrial goods.
Mr. Christensen holds two degrees from Duke University in Durham, North Carolina, where he also won a national basketball championship, Mr. Christensen also holds an MBA from Harvard Business School.
Dr. Dillon was raised in Lisbon, Connecticut and graduated from Boston University with a Bachelor of Science in Human Physiology. She completed a Master of Science in Pathology at the University of Vermont Medical Center and focused her thesis on HPV infection and its potential etiologic role in colorectal cancer. After graduate school, she worked at Maitri Healthcare for Women as a medical assistant and subsequently completed her Doctor of Medicine at Ross University School of Medicine.
She is currently a third year AP/CP Pathology Resident at Dartmouth-Hitchcock Medical Center in Lisbon, Connecticut. Her activities with the College of American Pathologists (CAP) include Resident Forum Delegate, recently elected Junior Member of the Reproductive Medicine Committee, and anticipated participation in the Engaged Leadership Academy next month in Chicago, Illinois. Upon graduation from residency in June 2018, she will be a Fellow at Johns Hopkins Hospital, subspecializing in Gynecologic and Perinatal Pathology.
Dr. Emory is a pathologist with Peninsula Pathology Associates in eastern Virginia and serves as the medical director of three laboratories within the Riverside Health System. Following several years at the Armed Forces Institute of Pathology, she spent 13 years as a pathologist in the Appalachian Mountains of southwestern Virginia and east Tennessee. During her time in that region, she was active in the United Way of Russell and Washington Counties and served as capital campaign chair in 2011. This campaign exceeded its fundraising goal of $1.1 million, raising more than $2 million dollars. Dr. Emory has been involved with several other non-profit organizations including: William King Regional Arts, Abuse Alternatives, Southwest Virginia Second Harvest Food Bank, Healing Hands, and Crossroads Medical Missions. She brings an understanding of the needs of rural underserved populations and strategies to reach financial goals.
Dr. Emory received her MD at the Eastern Virginia Medical School, where she now serves on the Board of Visitors. She completed her anatomic and clinical pathology residency at the Mayo Clinic, where she serves on the alumni association board of directors. She currently serves on the Payment Policy Subcommittee of the Economic and Regulatory Affairs Committee of the CAP and previously served on Federal and State Affairs Committee of the CAP.
Dr. Garrett is a native of Philadelphia and currently practices general surgical and cytopathology as a locum tenens pathologist. He received his undergraduate degree at Muhlenberg College in Allentown, Pennsylvania, and his medical degree from the Philadelphia College of Osteopathic Medicine. He completed his residency in AP/CP in the Army at Tripler Army Medical Center in Hawaii, and later in career a fellowship in cytopathology at Drexel University in Philadelphia. After residency, he served for ten years as a staff pathologist in the US Army, both at the 34th General Hospital in Augsburg, Germany, and at Letterman Army Medical Center in San Francisco. After leaving the military, he entered private practice in the San Francisco Bay Area working in both the hospital and outpatient settings.
Dr. Garrett currently serves as Chair of PathPAC, the CAP’s bipartisan political action committee that solely represents pathologists at the federal level. In addition, he is a member of the CAP Inspection Process Committee and is actively involved in the international accreditation program. Dr. Garrett is board certified in anatomic and clinical pathology with sub-specialty board certification in cytopathology.
Dr. Janes recently retired from the US Centers for Disease Control and Prevention (CDC), where she served as a senior health scientist in the Office of the Associate Director of Policy, has worked broadly in the area of public health and health outcomes, and is a specialist in health data policy and evidence-based processes. She completed her doctoral studies at Georgetown University in cell biology and received an MS in biostatistics from the University of Illinois at Chicago. While at CDC, she worked closely with the Centers for Medicare and Medicaid Services (CMS) on implementation of the Affordable Care Act, and its impact on public health programs and community-based services.
Dr. Jennifer Laudadio recently served as the CAP Foundation president and continues her volunteerism as a director. She is an Associate Professor of Pathology at the University of Arkansas for Medical Sciences (UAMS), Dr. Laudadio is a graduate of the Medical College of Georgia. She completed her residency at Medical University of South Carolina and a Fellowship in Molecular Genetic Pathology at Oregon Health and Science University. Dr. Laudadio serves as Medical Director for the UAMS Laboratory Service Line. She is a residency program director and serves on the CAP curriculum committee. Her dedication to education and passion for providing quality patient care are natural links to the mission of the CAP Foundation.
Joseph Lucci III, MD is a Board Certified Gynecologic Oncologist in practice since 1986. He earned his medical degree at the University of Texas Health Science Center at Houston now known as McGovern Medical School at UTHealth. This was followed by a residency in Obstetrics and Gynecology at Christus St. Joseph Hospital in Houston and a fellowship in Gynecologic Oncology at the University of California Irvine Medical Center.
Dr. Lucci treats patients of all ages. His clinical interests include the treatment of gynecologic cancer, cervical cancer, human papillomavirus (HPV) and ovarian cancer. He strongly believes the goal of cancer treatment is to encourage the patients to live life to the fullest and have the ability to pursue imminent opportunities while obtaining the highest quality of care. His focus on the patient’s needs and desires ensures a high level of comfort and compassion.
Dr. Misialek currently serves as associate chair of pathology at Newton-Wellesley Hospital, in Newton, Massachusetts. He is the medical director of the Vernon Cancer Center, Chemistry Laboratory and Point of Care Testing. He practices in all areas of pathology in a busy community hospital. Holding an academic appointment at Tufts University School of Medicine as a clinical assistant professor of pathology, he regularly instructs medical students and pathology residents. Dr. Misialek is a strong advocate for pathology and is very active in the College of American Pathologists (CAP), serving on the Personalized Healthcare Committee, the Council for Membership and Professional Development, the CAP’s political action committee, PathPAC, and in the CAP House of Delegates as chair of the Massachusetts delegation. He is an inspector with the CAP’s Laboratory Accreditation Program and is a member of the Clinical and Laboratory Standards Institute Document Development Committee on Reporting Critical, Life-Threatening, or Life-Altering Lab Results.
He received his MD from the University of Massachusetts, did an internship in internal medicine at Boston Medical Center, completed his residency in anatomic and clinical pathology at the University of Massachusetts Medical Center, and did a fellowship in general surgical pathology at the University of Florida. Dr. Misialek is board certified in anatomic and clinical pathology.
Dr. Ring served as the Chairman of Pathology and Medical Director of laboratories with over 30 years of experience. He has held many academic positions at Stanford University, University of New York, University of Illinois College of Medicine, Florida Atlantic University, where he is presently a clinical professor.
As the only physician executive at ESC, he was engaged in community work as a consultant with not-for-profit community organizations which included mentoring high school students, serving on the board of the Association for Brain Tumor Research, and an appointment to the resource committee for the Chicago Public Schools project. He serves the CAP as an inspector of laboratories and teaching institutions, is the Chairman of the Taskforce on Emeritus Members, and also served on the House of Delegates, PathPAC board, and various additional committees.
Dr. Robazetti is an assistant professor of OB/GYN at The University of Texas Health Science Center at Houston. She is a physician by training from Venezuela. She has dedicated her career to research especially in the field of cervical cancer and HPV. Dr. Robazetti also serves as a co-chair of the National Cervical Cancer Coalition. Her personal purpose is helping disadvantaged women to get free cervical and breast cancer screening and organizing heath screening events in Houston. She has been actively involved in the See, Test & Treat® program since 2011.
Mr. Serafy is president and CEO of Proficiency Testing Service, located in Brownsville, Texas. The company specializes in providing quality management testing programs used by medical laboratories and health care organizations to assess, monitor, and improve the accuracy and reliability of their diagnostic test results.
Mr. Serafy is chairman of the Cameron County Spaceport Development Corporation, serves on the board of directors of both the International Bank of Commerce-Brownsville and the Brownsville Economic Development Corporation, and serves on the executive committee of the Texas Business Leadership Council. He is also a member of the board of trustees of Schreiner University in Kerrville, Texas, and the University of Dallas.
Mr. Serafy received his BA in microbiology from The University of Texas at Austin in 1978.
Dr. Vance brings her experience as pathologist, clinician, laboratory director, and educator to the CAP Foundation board. Currently, she directs the Diagnostic Genomics laboratories of the Indiana University School of Medicine’s Department of Medical and Molecular Genetics, as well as the department’s Medical Genetics clinical program. She has previously worked with the CAP Foundation, serving as board liaison from 2010 to 2012, and is extremely active within CAP as a whole. She served on the CAP Board of Governors from 2005-2012, has served on numerous committees and advisory groups within the CAP, and has been a CAP laboratory inspector for over 15 years.
Dr. Wojcik is the Chair of the Department of Pathology and endowed Professor of Pathology and Urology at Loyola University Medical Center. She is a renowned pathologist who has a special interest in genito-urinary cytopathology. Dr. Wojcik is certified in Anatomic Pathology and Clinical Pathology as well as Cytopathology by the American Board of Pathology. Dr. Wojcik is an immediate Past President of the American Society of Cytopathology and an Associate Editor of the Journal of the American Society of Cytopathology. She serves on editorial boards of Diagnostic Cytopathology and Archives of Pathology and Laboratory Medicine. Dr. Wojcik has been a frequent invited speaker at numerous international, national and regional forums. Most of her presentations are dealing with recent advances in urine cytology. She led international efforts to standardize reporting of urinary cytology that culminated with publication of The Paris System for Reporting Urinary Cytology. Dr Wojcik is an active member of CAP and last year she organized the first in the Chicago land area See, Test & Treat. This year, again, she led the Loyola’s efforts to conduct another See, Test & Treat that was very successful. She is a contributor to PathPAC.
Gerald R. Hanson, MD, FCAP
Bharati Suketu Jhaveri, MD, FCAP
Send this to friend